| Financial Year |
March 31 2023 |
| Monetary Funds |
1,388,905,370.37 |
| Held-for-trading Financial Assets |
4,864,338,823.79 |
| Notes Receivable |
-- |
| Accounts Receivable |
32,368,491.35 |
| Advances to Suppliers |
162,467,364.33 |
| Other Receivables |
40,812,091.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,930,244,103.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,700,959.78 |
| Total Current Assets |
8,899,778,708.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,672,937.80 |
| Investment Properties |
-- |
| Fixed Assetes |
4,626,516,998.96 |
| Under-construction Projects |
1,089,772,377.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
423,799,236.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,181,783.16 |
| Other Non-Current Assets |
658,066,037.76 |
| Sub-Total of Non-Current Assets |
7,780,754,637.72 |
| Total Assets |
16,680,533,345.79 |
| Short-Term Loans |
1,640,847,499.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,975,564,646.52 |
| Accounts Payable |
1,739,239,681.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
88,229,355.24 |
| Taxes Payable |
55,075,053.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
339,370,471.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
81,889,142.45 |
| Sub-Total of Current Liabilities |
6,433,634,002.05 |
| Long-term Loans |
196,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
78,253,368.27 |
| Other Non-Current Liabilities |
8,976,152.35 |
| Sub-Total of Non-Current Liabilities |
369,385,444.23 |
| Total Liabilities |
6,803,019,446.28 |
| Paid-In Capital(Or Share Stock) |
2,206,771,772.00 |
| Capital Surplus |
-608,601,669.40 |
| Surplus Reserve |
255,844,230.88 |
| LESS:Treasury Stock |
165,384,873.93 |
| Undistributed Profits |
4,760,165,608.64 |
| Minority Stockholder's Interest |
3,419,196,709.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,458,317,190.30 |
| Owner's Equity（Stockholder's Equity） |
9,877,513,899.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,680,533,345.79 |
